System1 appoints Charles Ursini and Ryan Caswell to board; board expands to 11
System1, Inc.
Charles Ursini (Class II director, up for re-election at 2024 annual meeting) and Ryan Caswell (Class III director, up for re-election at 2025 annual meeting) appointed.
Ryan Caswell is President of Cannae Holdings (NYSE: CNNE) and qualifies as independent; Ursini is a co-founder on senior management team and not independent.
Board size increased from 10 to 11 directors; the new seat is a Class III position expiring at the 2025 annual meeting.
Caswell will receive pro-rated compensation under the Non-Employee Director Compensation Program; both directors will enter indemnification agreements.
On April 10, 2024, the Board of Directors (the “Board”) of System, Inc. (the “Company”) appointed Charles Ursini to serve as a Class II director and Ryan Caswell to serve as a Class III director of the Board.
On April 10, 2024, the Board of Directors (the “Board”) of System, Inc. (the “Company”) appointed Charles Ursini to serve as a Class II director and Ryan Caswell to serve as a Class III director of the Board.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Ryan Caswell was appointed as Director at System1, Inc..
Action
appointed
Role
Director
Exact text from the filing
On April 10, 2024, the Board of Directors (the “Board”) of System, Inc. (the “Company”) appointed Charles Ursini to serve as a Class II director and Ryan Caswell to serve as a Class III director of the Board.
Charles Ursini was appointed as Director at System1, Inc..
Action
appointed
Role
Director
Exact text from the filing
On April 10, 2024, the Board of Directors (the “Board”) of System, Inc. (the “Company”) appointed Charles Ursini to serve as a Class II director and Ryan Caswell to serve as a Class III director of the Board.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.